Koen van Besien MD PhD (He/Him)

PubMed

• 17 citations
  Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
  Jia Ruan, Alison Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen
  Blood. 2023-05-04
• 2 citations
  Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation.
  Mohammad Alhomoud, Nora Chokr, Alexandra Gomez-Arteaga, Zhengming Chen, Joanna G Escalon
  Transplantation and Cellular Therapy. 2023-05-01
• 6 citations
  Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients.
  Chandni Patel, Michelle Pasciolla, Rachel Abramova, David Salerno, Alexandra Gomez-Arteaga
  Transplantation and Cellular Therapy. 2023-02-01

Abstracts/Posters

• Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...
  Koen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion
  Koen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration
  Koen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Inferior Survival with Use of Autologous Stem Cell Transplant As Second-Line Therapy in Multiple Myeloma
  Koen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Similar Survival with Deferred Versus Salvage Autologous Stem Cell Transplant in Light Chain Amyloidosis
  Koen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial o... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant? 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all